From: Recent advances in extracellular vesicle engineering and its applications to regenerative medicine
No. | Target cell | Treatment material | Concentration | Ref. |
---|---|---|---|---|
1 | UCMSC | IFN-γ | 50 ng/ml | [65] |
2 | GMSC | TNF-α | 10 ng/ml | [66] |
3 | BMSC | TNF-α, IFN-γ | 15 ng/ml; 10 ng/ml | [67] |
4 | BMSC | TNF-α, IFN-γ | 20 ng/ml; 20 ng/ml | [68] |
5 | UCMSC | TNF-α, IFN-γ | 20 ng/ml; 20 ng/ml | [69] |
6 | UCMSC | TNF-α, IFN-γ | 20 ng/ml; 20 ng/ml | [21] |
7 | UCMSC | TNF-α, IFN-γ | 20 ng/ml; 20 ng/ml | [70] |
8 | GMSC | TNF-α, IFN-α | 50 ng/ml; 50 ng/ml | [72] |
9 | BMSC | IL-1β | 10 ng/ml | [73] |
10 | BMSC | IL-1β | 10 ng/ml | [74] |
11 | BMSC | LPS | 100 ng/ml | [75] |
12 | BMSC | LPS | 100 ng/ml | [76] |